Xylocaine 1% Inj, 20ml

Manufacturer FRESENIUS Active Ingredient Lidocaine Injection Solution (Anesthetic)(LYE doe kane) Pronunciation LYE-doe-kane
It is used to numb an area before a procedure.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Local Anesthetic
đŸ§Ŧ
Pharmacologic Class
Voltage-gated sodium channel blocker
🤰
Pregnancy Category
Category B
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lidocaine is a medicine used to numb a specific area of your body to prevent pain during minor medical procedures, like stitches or dental work. It works by temporarily blocking nerve signals in that area.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as prescribed, and adhere to all guidelines provided. This medication is administered via injection.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

In the event that you miss a dose, contact your doctor to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products.
  • Report any unusual symptoms or discomfort during or after the procedure.
  • Avoid touching or manipulating the numb area excessively to prevent injury until sensation returns.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For infiltration: 0.5% to 1% solution. Max single dose without epinephrine: 4.5 mg/kg (not to exceed 300 mg). Max single dose with epinephrine: 7 mg/kg (not to exceed 500 mg).

Condition-Specific Dosing:

infiltration: Up to 300 mg (without epi) or 500 mg (with epi) per single administration.
nerveBlock: Varies by block type and site, typically 50-300 mg.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; use with extreme caution and reduced doses if necessary. Max 2-3 mg/kg.
Infant: Max single dose: 3-5 mg/kg (without epinephrine).
Child: Max single dose: 3-5 mg/kg (without epinephrine), not to exceed 300 mg.
Adolescent: Max single dose: 3-5 mg/kg (without epinephrine), not to exceed 300 mg, or adult dosing if weight appropriate.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required for single-dose local anesthesia.
Moderate: No specific dose adjustment generally required for single-dose local anesthesia, but monitor for toxicity with repeated or large doses.
Severe: Consider reduced doses and monitor for toxicity, especially with repeated or large doses, due to potential accumulation of metabolites.
Dialysis: Lidocaine is not significantly removed by hemodialysis. Adjustments based on clinical response and toxicity.

Hepatic Impairment:

Mild: No specific dose adjustment generally required for single-dose local anesthesia.
Moderate: Consider reduced doses (e.g., 50% reduction) and monitor for toxicity, especially with repeated or large doses, due to impaired metabolism.
Severe: Significant dose reduction (e.g., 50-75% reduction) is required. Monitor closely for signs of systemic toxicity. Avoid if possible.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. It blocks voltage-gated sodium channels in the neuronal cell membrane, preventing the influx of sodium ions and thus inhibiting depolarization and propagation of action potentials.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable (depends on site of administration, vascularity, presence of vasoconstrictor)
Tmax: Variable (2-10 minutes for infiltration, longer for nerve blocks)
FoodEffect: Not applicable for injectable form

Distribution:

Vd: 0.7-2.7 L/kg
ProteinBinding: 60-80% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes

Elimination:

HalfLife: 1.5-2 hours (prolonged in hepatic impairment, heart failure)
Clearance: Approximately 10 mL/min/kg
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: Less than 10% (as unchanged drug)
âąī¸

Pharmacodynamics

OnsetOfAction: 2-5 minutes (for infiltration)
PeakEffect: 5-15 minutes
DurationOfAction: 0.5-3 hours (without epinephrine); 2-6 hours (with epinephrine)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Methemoglobinemia: A blue or gray color of the lips, nails, or skin, abnormal heartbeat, seizures, severe dizziness or fainting, severe headache, excessive sleepiness, feeling tired or weak, or shortness of breath. This rare condition can be life-threatening if left untreated.
Acidosis (Too Much Acid in the Blood): Confusion, rapid breathing, rapid heartbeat, abnormal heartbeat, severe stomach pain, nausea, vomiting, excessive sleepiness, shortness of breath, or feeling extremely tired or weak.
Respiratory Problems: Trouble breathing, slow breathing, or shallow breathing.
Central Nervous System Effects: Feeling lightheaded, sleepy, confused, or experiencing blurred vision.
Cardiovascular Effects: Slow heartbeat.
Neurological Effects: Feeling nervous and excitable, trouble speaking, burning, numbness, or tingling sensations, restlessness, anxiety, changes in vision, ringing in the ears, dizziness or fainting, severe headache, twitching, shakiness, seizures, feeling hot or cold, or metallic taste.
Cardiac Effects: Chest pain.
Mood Changes: Changes in mood.

Additional Side Effects (Injection into the Spine):

Sexual Dysfunction: Difficulty getting or maintaining an erection.
Motor Function: Loss of movement or control over stools and urine.
Urinary Problems: Trouble passing urine.

Other Side Effects

Not everyone experiences side effects, and many people have only minor side effects. However, if you notice any side effects that bother you or persist, contact your doctor for advice. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Feeling lightheaded or dizzy
  • Ringing in your ears (tinnitus)
  • Numbness or tingling around your mouth
  • Unusual anxiety or nervousness
  • Muscle twitching or tremors
  • Blurred vision
  • Difficulty breathing
  • Slow or irregular heartbeat
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

To ensure safe treatment, inform your doctor about the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you experienced.
If you are scheduled to receive this medication via spinal injection, tell your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site

It is crucial to disclose all your health conditions and medications to your doctor and pharmacist, including:
Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins

This will help determine if it is safe to take this medication with your existing health conditions and other drugs. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Risk of Methemoglobinemia
A severe blood disorder called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Heart problems
Lung problems
Are taking certain other medications
Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.

Sulfite Allergy
If you are allergic to sulfites, consult your doctor, as some products may contain sulfites.

Caution with Daily Activities
Avoid driving and performing tasks that require alertness until the effects of this medication have worn off and you feel fully awake.

Protecting the Treated Area
If you are discharged before the numbness has resolved, take precautions to protect the treated area from injury until you have regained sensation.

Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor.

Injection (Spinal Administration)
This medication may cause temporary loss of sensation and motor function in the lower half of your body. Do not attempt to get out of bed or perform tasks until feeling and motor function have returned to normal.

Mouth and Dental Procedures
Do not eat while your mouth is numb, as you may inadvertently bite your tongue.
🆘

Overdose Information

Overdose Symptoms:

  • Severe dizziness or lightheadedness
  • Confusion or disorientation
  • Slurred speech
  • Seizures
  • Loss of consciousness
  • Slow heart rate (bradycardia)
  • Low blood pressure (hypotension)
  • Cardiac arrest

What to Do:

If you experience any of these severe symptoms, seek immediate medical attention. Call 911 or your local emergency number. For general overdose information, contact a poison control center at 1-800-222-1222.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Known hypersensitivity to amide-type local anesthetics
  • Stokes-Adams syndrome
  • Severe degrees of heart block (e.g., second or third-degree AV block) without a pacemaker (when used as antiarrhythmic, but caution for local use if systemic absorption is high)
🔴

Major Interactions

  • Antiarrhythmics (Class I, e.g., mexiletine, procainamide): Additive cardiac effects, increased risk of toxicity.
  • Beta-blockers (e.g., propranolol, metoprolol): May decrease hepatic clearance of lidocaine, increasing plasma levels and risk of toxicity.
  • Cimetidine: May inhibit lidocaine metabolism, increasing plasma levels and risk of toxicity.
🟡

Moderate Interactions

  • Succinylcholine: May prolong neuromuscular blockade.
  • Phenytoin: May increase lidocaine metabolism (less common interaction).
  • MAOIs, TCAs, phenothiazines (if lidocaine contains epinephrine): May cause severe prolonged hypertension or arrhythmias.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Allergy history

Rationale: To identify hypersensitivity to amide-type local anesthetics.

Timing: Prior to administration

Vital signs (heart rate, blood pressure, respiratory rate)

Rationale: To establish baseline and detect early signs of systemic toxicity.

Timing: Prior to administration

Patient's general condition and comorbidities

Rationale: To assess risk factors for toxicity (e.g., cardiac, hepatic impairment).

Timing: Prior to administration

📊

Routine Monitoring

Vital signs (heart rate, blood pressure, respiratory rate)

Frequency: During and immediately after administration, then as clinically indicated.

Target: Within patient's normal range

Action Threshold: Significant deviations (e.g., bradycardia, hypotension, respiratory depression) warrant immediate intervention.

Neurological status (mental status, presence of tremors, dizziness)

Frequency: During and immediately after administration, then as clinically indicated.

Target: Alert and oriented, no abnormal neurological signs

Action Threshold: Signs of CNS toxicity (e.g., circumoral numbness, tinnitus, dizziness, agitation, muscle twitching, seizures) require immediate intervention.

ECG monitoring (for large doses or high-risk patients)

Frequency: Continuous during administration of large doses or in patients with cardiac disease.

Target: Normal sinus rhythm, no conduction abnormalities

Action Threshold: Arrhythmias, conduction delays (e.g., QRS widening), or bradycardia require immediate intervention.

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus (ringing in ears)
  • Perioral numbness or tingling
  • Metallic taste
  • Blurred vision
  • Tremors or muscle twitching
  • Nervousness or anxiety
  • Drowsiness or sedation
  • Slurred speech
  • Seizures
  • Bradycardia
  • Hypotension
  • Cardiac arrest

Special Patient Groups

🤰

Pregnancy

Lidocaine is generally considered safe for use as a local anesthetic during pregnancy (Pregnancy Category B). It crosses the placenta but is rapidly metabolized. Use the lowest effective dose.

Trimester-Specific Risks:

First Trimester: No increased risk of congenital anomalies observed in human studies.
Second Trimester: Generally considered safe for local anesthetic procedures.
Third Trimester: Generally considered safe for local anesthetic procedures, commonly used in obstetrics (e.g., epidural anesthesia).
🤱

Lactation

Lidocaine is excreted into breast milk in small amounts. The amount transferred to the infant is generally considered too small to cause adverse effects. It is rated L2 (likely compatible) by LactMed. Use the lowest effective dose.

Infant Risk: Low risk of adverse effects to the breastfed infant. Monitor infant for sedation or feeding difficulties, though unlikely.
đŸ‘ļ

Pediatric Use

Pediatric patients, especially infants and young children, are more susceptible to systemic toxicity due to differences in metabolism, distribution, and higher relative doses per body weight. Dosing must be carefully calculated based on weight (mg/kg) and the lowest effective concentration and volume should be used. Close monitoring for signs of systemic toxicity is crucial.

👴

Geriatric Use

Elderly patients may have reduced hepatic blood flow and metabolism, leading to higher plasma concentrations and increased risk of systemic toxicity. Lower doses may be required, and careful monitoring for adverse effects is recommended. Co-morbidities (e.g., cardiac, renal impairment) should be considered.

Clinical Information

💎

Clinical Pearls

  • Always aspirate prior to injection to ensure the needle is not in a blood vessel, which can lead to rapid systemic absorption and toxicity.
  • Use the lowest effective concentration and volume to achieve the desired anesthetic effect.
  • The addition of epinephrine (vasoconstrictor) prolongs the duration of action and reduces systemic absorption, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, penis, ears) due to risk of ischemia.
  • Be vigilant for signs of Local Anesthetic Systemic Toxicity (LAST), which can manifest as CNS symptoms (e.g., circumoral numbness, tinnitus, seizures) or cardiovascular symptoms (e.g., bradycardia, hypotension, arrhythmias). Lipid emulsion therapy is the antidote for severe LAST.
  • Patients with cardiac conduction abnormalities (e.g., sick sinus syndrome, severe AV block) are at higher risk for cardiac adverse effects if systemic absorption occurs.
🔄

Alternative Therapies

  • Bupivacaine (longer duration of action)
  • Ropivacaine (less cardiotoxic than bupivacaine)
  • Mepivacaine (similar to lidocaine, slightly longer duration)
  • Prilocaine (less cardiotoxic, but risk of methemoglobinemia with high doses)
  • Chloroprocaine (ester-type, very short duration, rapid metabolism)
  • Topical anesthetics (e.g., benzocaine, tetracaine)
  • Cryoanalgesia
  • Non-pharmacological pain management techniques
💰

Cost & Coverage

Average Cost: Highly variable, typically low per vial/ampule
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred.